Mallax Pharmaceuticals - Stockholm, Sweden

Mallax seeks to capitalize on promising acquisition prospects in Europe. The company is determined to create a collection of proven pharmaceuticals and over-the-counter (OTC) products that customers and patients across Europe can access through mergers and alliances in the healthcare industry. This venture was initiated by Anders Larnholt, a pharma manager and businessperson, and Impilo, a Swedish investment firm concentrating on healthcare and Nordic organizations.